Goldman Sachs’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.3K | Buy |
|
|||||
|
2025
Q2 | $9.81K | Sell |
|
|||||
|
2025
Q1 | $13.1K | Sell |
|
|||||
|
2024
Q4 | $37.6K | Buy |
|
|||||
|
2024
Q3 | $14.1K | Sell |
|
|||||
|
2024
Q2 | $330K | Buy |
|
|||||
|
2024
Q1 | $86.3K | Sell |
|
|||||
|
2023
Q4 | $154K | Buy |
|
|||||
|
2023
Q3 | $44K | Buy |
|
|||||
|
2023
Q2 | $64.3K | Buy |
|
|||||
|
2023
Q1 | $49.7K | Sell |
|
|||||
|
2022
Q4 | $40.1K | Buy |
|
|||||
|
2022
Q3 | $31K | Sell |
|
|||||
|
2022
Q2 | $374K | Sell |
|
|||||
|
2022
Q1 | $735K | Sell |
|
|||||
|
2021
Q4 | $1.72M | Sell |
|
|||||
|
2021
Q3 | $3.42M | Sell |
|
|||||
|
2021
Q2 | $4.6M | Sell |
|
|||||
|
2021
Q1 | $7.35M | Buy |
|
|||||
|
2020
Q4 | $6.42M | Buy |
|
|||||
|
2020
Q3 | $5.08M | Buy |
|
|||||
|
2020
Q2 | $8.1M | Buy |
|
|||||
|
2020
Q1 | $2.22M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $147K | Buy |
|